{"id":"https://genegraph.clinicalgenome.org/r/05e6265c-a6a7-419c-9dd5-d45958732464v1.1","type":"EvidenceStrengthAssertion","dc:description":"*COL1A2* has been repeatedly described in association with autosomal dominant Osteogenesis Imperfecta (OI) Type 2. OI type 2 is a lethal type of osteogenesis imperfecta, characterized by increased bone fragility, with many perinatal fractures, severe bowing of long bones, under mineralization, and death in the perinatal period. *COL1A2* has been noted to be associated with multiple disease entities. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in molecular mechanism, inheritance pattern, and phenotypic variability. Therefore, the following disease entities have been split into multiple disease entities,  osteogenesis imperfecta type II (OMIM:166210), osteogenesis imperfecta type III (OMIM:259420), osteogenesis imperfecta, type IV (OMIM:166220), Combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2\t(OMIM:619120), Ehlers-Danlos syndrome, arthrochalasia type, 2 (OMIM:617821), Ehlers-Danlos syndrome, cardiac valvular type (OMIM:225320), and Osteoporosis, postmenopausal.  At least 15 variants (missense, small deletion) that have been reported in 14 probands in 9 publications (PMIDs: 1301191, 1284475, 8424758, 11668615, 31299979, 9923651, 7906591, 7959683, 7891382) are included in this curation. Evidence supporting this gene-disease relationship includes case-level data. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. In summary, *COL1A2* is definitively associated with autosomal dominant Osteogenesis Imperfecta Type 2. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Skeletal Disorders GCEP on the meeting date 2/7/22 (SOP Version 9).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/05e6265c-a6a7-419c-9dd5-d45958732464","GCISnapshot":"https://genegraph.clinicalgenome.org/r/3c78279e-c9c8-4ff7-a206-db78a30cd5d6","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/3c78279e-c9c8-4ff7-a206-db78a30cd5d6_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2023-09-28T19:55:59.063Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/3c78279e-c9c8-4ff7-a206-db78a30cd5d6_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2023-09-28T16:00:00.000Z","role":"Approver"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c78279e-c9c8-4ff7-a206-db78a30cd5d6_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d8166775-9ba7-4a18-9969-5a6cc68b051f","type":"EvidenceLine","dc:description":"Variant disrupts the Gly-X-Y triple helix","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d8166775-9ba7-4a18-9969-5a6cc68b051f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8424758","allele":{"id":"https://genegraph.clinicalgenome.org/r/831523c7-a24c-48b2-a779-e844d538cfda","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.730G>T (p.Gly244Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368220403"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ea1d41ee-0394-4b30-b586-a9a17b8bfa98","type":"EvidenceLine","dc:description":"Variant disrupts the Gly-X-Y triple helix","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea1d41ee-0394-4b30-b586-a9a17b8bfa98_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32360156","allele":{"id":"https://genegraph.clinicalgenome.org/r/1ea04fea-361c-4c13-8904-ca3152b27482","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.1496G>A (p.Gly499Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368221963"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ee6ccbf4-2671-450b-b66a-c35a4077ec53","type":"EvidenceLine","dc:description":"Variant disrupts Gly-X-Y triple helix.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee6ccbf4-2671-450b-b66a-c35a4077ec53_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7891382","allele":{"id":"https://genegraph.clinicalgenome.org/r/4f6d7ec8-adae-4a9b-9564-25001775a307","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.2188G>T (p.Gly730Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA162935938"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/46f3f75e-4662-4569-9775-ed7fdb37c625","type":"EvidenceLine","dc:description":"Variant disrupts Gly-X-Y triple helix ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/46f3f75e-4662-4569-9775-ed7fdb37c625_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7906591","allele":{"id":"https://genegraph.clinicalgenome.org/r/6b3fd5b7-d8f7-43bb-94e7-f837e7c693d2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.1298G>A (p.Gly433Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA162922055"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3c78279e-c9c8-4ff7-a206-db78a30cd5d6_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7d5bf284-70b9-4820-a783-e5fc212d09e7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1301191","rdfs:label":"Family 1","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/7d5bf284-70b9-4820-a783-e5fc212d09e7","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/a927a249-1e38-40f2-81d1-c89872dfffa8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1301191","rdfs:label":"II-2","allele":{"id":"https://genegraph.clinicalgenome.org/r/bcf007f3-ba85-4da1-b9d9-77e89b91afae","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.1414G>T (p.Gly472Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA257768"}},"detectionMethod":"Variant confirmed via Sau1 mapping. ","firstTestingMethod":"PCR","phenotypes":["obo:HP_0005622","obo:HP_0003026","obo:HP_0005474","obo:HP_0004348"],"secondTestingMethod":"Restriction digest","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/e48db1ea-52ab-4876-84d4-72f0c53bc12d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1301191","allele":{"id":"https://genegraph.clinicalgenome.org/r/bcf007f3-ba85-4da1-b9d9-77e89b91afae"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/a927a249-1e38-40f2-81d1-c89872dfffa8"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/daab86f0-7f7e-47b8-b555-85988df1a56b","type":"EvidenceLine","dc:description":"Variant disrupts the Gly-X-Y triple helix","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/daab86f0-7f7e-47b8-b555-85988df1a56b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7959683","allele":{"id":"https://genegraph.clinicalgenome.org/r/e61f595b-194c-4f1f-9cbc-27af7b4c628a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.1504G>A (p.Gly502Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA257783"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5b615895-43ce-4ee7-a784-3b9af21e51cd","type":"EvidenceLine","dc:description":"Downgraded to equal scoring of Gly-X-Y triple helix variant","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5b615895-43ce-4ee7-a784-3b9af21e51cd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11668615","allele":{"id":"https://genegraph.clinicalgenome.org/r/da117157-8353-43dc-a3ee-71c44af6744d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.2113_2121del (p.Ala705_Pro707del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA162935358"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a4c7dbd1-da46-47bf-8779-25b57b41cd14","type":"EvidenceLine","dc:description":"Variant disrupts Gly-X-Y triple helix","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a4c7dbd1-da46-47bf-8779-25b57b41cd14_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27433940","allele":{"id":"https://genegraph.clinicalgenome.org/r/e349509a-9100-4f86-8de7-6bf36cb2962d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.1774G>A (p.Gly592Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1224306"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/eec0ad42-2481-4d1d-93a2-7a9a5a141043","type":"EvidenceLine","dc:description":"Variant disrupts the Gly-X-Y triple helix ","calculatedScore":1,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eec0ad42-2481-4d1d-93a2-7a9a5a141043_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7693712","allele":{"id":"https://genegraph.clinicalgenome.org/r/75dd0080-9970-4d30-8f7a-fdbdc926275a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.2386G>A (p.Gly796Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA162937252"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/eec0ad42-2481-4d1d-93a2-7a9a5a141043_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Proband synthesized two forms of type I collagen from dermal fibroblasts : \nform with normal electrophoretic mobility, and  form with delayed electrophoretic mobility\n\nThe abnormally migrating forms of type I collagen are well secreted by the cells and can be equally demonstrated in the media and in the cell layer.\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/1067ba54-f8d3-4476-bd71-ef04baf66715","type":"EvidenceLine","dc:description":"Downgraded to equal scoring of Gly-X-Y triple helix variant","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1067ba54-f8d3-4476-bd71-ef04baf66715_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11668615","allele":{"id":"https://genegraph.clinicalgenome.org/r/2c8744fa-9572-4660-a4cb-b0cb9c33bcee","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.2712_2729del (p.Arg906_Ala911del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA162939388"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1d6fe093-6ffd-4caf-a94e-10be1ae237ae","type":"EvidenceLine","dc:description":"Variant disrupts Gly-X-Y triple helix","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d6fe093-6ffd-4caf-a94e-10be1ae237ae_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31299979","allele":{"id":"https://genegraph.clinicalgenome.org/r/e349509a-9100-4f86-8de7-6bf36cb2962d"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c27d2c90-ba35-4496-a8b9-08c520557751","type":"EvidenceLine","dc:description":"Upgraded based on pathogenicity of Gly-X-Y triple helix disruption","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c27d2c90-ba35-4496-a8b9-08c520557751_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/1284475","allele":{"id":"https://genegraph.clinicalgenome.org/r/ce76ebe8-bbd2-49b0-8e74-b2a928eab2ee","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.1774G>C (p.Gly592Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA368222577"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/c27d2c90-ba35-4496-a8b9-08c520557751_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Tissue analysis of O145  dermis and bone showed that there was a marked reduction in tissue collagen content. Collagen levels were ~50% of control values. Fibroblast collagen secretion was 60% compared to control values. increased degradation of the mutant collagen from the incorporation of the mutant pro-a2(I)\n","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/379d4b3c-ffd7-4dd7-9d84-5ef18b55e48a","type":"EvidenceLine","dc:description":"Variant disrupts Gly-X-Y triple helix","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/379d4b3c-ffd7-4dd7-9d84-5ef18b55e48a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7959683","allele":{"id":"https://genegraph.clinicalgenome.org/r/e61f595b-194c-4f1f-9cbc-27af7b4c628a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/aedc4fd9-023e-45a8-b486-c43c76d5ebdf","type":"EvidenceLine","dc:description":"The variant disrupts the Gly-X-Y triple helix","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aedc4fd9-023e-45a8-b486-c43c76d5ebdf_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9923651","allele":{"id":"https://genegraph.clinicalgenome.org/r/22f8fe4d-aa1c-4323-9f60-333a06a60fed","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.1532G>A (p.Gly511Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA162925848"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/aedc4fd9-023e-45a8-b486-c43c76d5ebdf_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The Gly511Asp variant was shown to cause a marked electrophoretic delay of mutant alpha-2(1) chains in both the glycosylated and unglycosylated forms, due to helical kinking\naround the position of the mutation. ","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/298b1a1c-8442-443b-bf9f-592d38fef85c","type":"EvidenceLine","dc:description":"Variant disrupts Gly-X-Y triple helix","calculatedScore":0.5,"direction":"Inconclusive","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/298b1a1c-8442-443b-bf9f-592d38fef85c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31299979","allele":{"id":"https://genegraph.clinicalgenome.org/r/72bfaf56-8011-415f-bf2f-aef700e7f0f1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.1072G>A (p.Gly358Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA162920823"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/33c6127e-cc28-4770-a6bc-96ea8abccd3d","type":"EvidenceLine","dc:description":"Variant disrupts Gly-X-Y triple helix","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33c6127e-cc28-4770-a6bc-96ea8abccd3d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8424758","allele":{"id":"https://genegraph.clinicalgenome.org/r/ec123be0-8cf3-4440-8743-2879f04b6a6e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000089.4(COL1A2):c.2359G>T (p.Gly787Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA162937206"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/22027452-d220-47d5-9a8f-2ef13eade596","type":"EvidenceLine","dc:description":"Variant disrupts the Gly-X-Y triple helix","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/22027452-d220-47d5-9a8f-2ef13eade596_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7959683","allele":{"id":"https://genegraph.clinicalgenome.org/r/e61f595b-194c-4f1f-9cbc-27af7b4c628a"},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/b5c8a15d-b255-4db2-8dfc-b16a9c6c2302","type":"EvidenceLine","dc:description":"Scored similarity to Gly-X-Y triple helix variant. Upgraded for radiograph  and ultrasound specificity","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b5c8a15d-b255-4db2-8dfc-b16a9c6c2302_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22795120","allele":{"id":"https://genegraph.clinicalgenome.org/r/345f39ad-6d0a-4655-8e70-fc5d736fb1b7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000007.14:g.94409821_94409823del (GRCh38)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA162920418"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e48db1ea-52ab-4876-84d4-72f0c53bc12d","type":"EvidenceLine","dc:description":"Variant disrupts the Gly-X-Y triple helix.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e48db1ea-52ab-4876-84d4-72f0c53bc12d_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/3c78279e-c9c8-4ff7-a206-db78a30cd5d6_experimental_evidence_line","type":"EvidenceLine","specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0}],"evidenceStrength":"Definitive","sequence":6989,"specifiedBy":"GeneValidityCriteria9","strengthScore":12,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ic_rmnVzgC0","type":"GeneValidityProposition","disease":"obo:MONDO_0008147","gene":"hgnc:2198","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_3c78279e-c9c8-4ff7-a206-db78a30cd5d6-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}